Evidence map›Paper›PMID 41670744›Full record

ArticleMikrochimica acta2026

Magnetic nanozyme-based dual-mode biosensor for highly sensitive detection of Yersinia pestis gene via hybridization chain reaction amplification.

Yunqing Zhang, Rui Yang, Na Lu

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yunqing ZhangSchool of Materials Science and Engineering, Shanghai University of Engineering Science, Shanghai, 201620, China.
Rui YangSchool of Materials Science and Engineering, Shanghai University of Engineering Science, Shanghai, 201620, China.
Na LuSchool of Materials Science and Engineering, Shanghai University of Engineering Science, Shanghai, 201620, China. nlu2014@163.com.

Funding

Open Project of Key Laboratory of Bioanalysis and Metrology, State Administration for Market Regulation A04202523004
6 · The paper itself

Abstract

Highly sensitive and accurate detection of Yersinia pestis is critical for effective plague control and biothreat mitigation. Here, we developed a dual-mode colorimetric and fluorescence biosensor based on a multifunctional magnetic nanozyme for Yersinia pestis gene detection, integrating hybridization chain reaction (HCR) for signal amplification and alkaline phosphatase (ALP)-mediated signaling. ALP hydrolyzes adenosine triphosphate (ATP) and L-ascorbic acid-2-phosphate trisodium salt (AA2P) to generate turn-off colorimetric and turn-on fluorescence signals, respectively. The bioassay exhibited good linearity for target genes from 1 pM to 10 nM, with limits of detection of 0.34 pM for colorimetric mode and 0.58 pM for fluorescent mode. It also showed excellent specificity, distinguishing perfectly matched targets from single- and two-base mismatched sequences. Most importantly, the dual-mode platform was successfully applied to spiked human serum samples with satisfactory recoveries. This strategy integrates magnetic separation, signal amplification, and dual-signal output for highly sensitive and specific gene detection, offering great potential for plague monitoring and clinical diagnosis.

Indexed as

Biosensing TechniquesMagnetite NanoparticlesYersinia pestisAlkaline PhosphataseColorimetryHumansLimit of DetectionNucleic Acid Amplification TechniquesNucleic Acid HybridizationAlkaline PhosphataseMagnetite NanoparticlesAlkaline phosphataseDual-mode biosensor; Fluorescence; ColorimetryHybridization chain reactionMagnetic nanozymeYersinia pestis gene

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.